Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors
V. Gunmalm,
N.R. Jørgensen
, B. Abrahamsen,
P. Schwarz
Department of Clinical Medicine
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Loss
100%
Metastatic Breast Cancer
100%
Aromatase Inhibitors
100%
Bisphosphonates
50%
Antiresorptive
33%
Denosumab
33%
Common Cancers
16%
Zoledronic Acid
16%
Breast Cancer
16%
Bone Health
16%
Breast Cancer Survivors
16%
Inhibitor Treatment
16%
Estrogen Receptor-positive Breast Cancer
16%
Fracture Prevention
16%
Randomized Controlled Study
16%
Randomized Controlled Trial
16%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatase Inhibitor
100%
Metastatic Breast Cancer
100%
Bisphosphonic Acid Derivative
60%
Denosumab
40%
Breast Cancer
40%
Randomized Controlled Trial
20%
Malignant Neoplasm
20%
Zoledronic Acid
20%
Estrogen Receptor Positive Breast Cancer
20%